The German Health Ministry commented on reports that the United States has bought up all stocks for the next three months of the anti-coronavirus drug remdesivir, leaving no products left for the rest of the world, during a press conference in Berlin on Wednesday.
«The federal government has secured at an earlier stage remdesivir for therapy for coronavirus patients,» said German Health Ministry spokesperson Oliver Ewald.
«At the moment, since we have a favourable situation with regards to the pandemic development (in Germany), and the medical intensive care, we have enough reserves,» he added.
The company behind the drug, Geliad, is under obligation to provide the EU with an appropriate amount of the medicine, according to the current agreement, Ewald added.
Government spokespeople meanwhile declared Berlin had decided to open its external borders from July 2 only for eight countries where the pandemic situation is similar to that in Germany, and where data is reliable.
For three other countries, including China, there will be a possibility to lift restrictions in case of an agreement for these countries to issue the same rules.